200 related articles for article (PubMed ID: 33432519)
1. Topical and transdermal delivery with diseased human skin: passive and iontophoretic delivery of hydrocortisone into psoriatic and eczematous skin.
Dasht Bozorg B; Bhattaccharjee SA; Somayaji MR; Banga AK
Drug Deliv Transl Res; 2022 Jan; 12(1):197-212. PubMed ID: 33432519
[TBL] [Abstract][Full Text] [Related]
2. Microneedle and iontophoresis mediated delivery of methotrexate into and across healthy and psoriatic skin.
Vora D; Garimella HT; German CL; Banga AK
Int J Pharm; 2022 Apr; 618():121693. PubMed ID: 35331833
[TBL] [Abstract][Full Text] [Related]
3. Iontophoretic transport kinetics of ketorolac in vitro and in vivo: demonstrating local enhanced topical drug delivery to muscle.
Gratieri T; Pujol-Bello E; Gelfuso GM; de Souza JG; Lopez RF; Kalia YN
Eur J Pharm Biopharm; 2014 Feb; 86(2):219-26. PubMed ID: 23791718
[TBL] [Abstract][Full Text] [Related]
4. Transdermal Iontophoretic Delivery of Lysine-Proline-Valine (KPV) Peptide Across Microporated Human Skin.
Pawar K; Kolli CS; Rangari VK; Babu RJ
J Pharm Sci; 2017 Jul; 106(7):1814-1820. PubMed ID: 28343991
[TBL] [Abstract][Full Text] [Related]
5. Transdermal iontophoretic delivery of terbinafine hydrochloride: quantitation of drug levels in stratum corneum and underlying skin.
Sachdeva V; Siddoju S; Yu YY; Kim HD; Friden PM; Banga AK
Int J Pharm; 2010 Mar; 388(1-2):24-31. PubMed ID: 20025950
[TBL] [Abstract][Full Text] [Related]
6. In vitro study of transdermal penetration and iontophoresis of hepatitis B vaccines through rat skin.
Xu T; Xu YH; Wei MY; Deng LH; Wu CB
Yao Xue Xue Bao; 2011 Jun; 46(6):713-9. PubMed ID: 21882534
[TBL] [Abstract][Full Text] [Related]
7. Combined effects of iontophoretic and chemical enhancement on drug delivery. II. Transport across human and murine skin.
Nolan LM; Corish J; Corrigan OI; Fitzpatrick D
Int J Pharm; 2007 Aug; 341(1-2):114-24. PubMed ID: 17502130
[TBL] [Abstract][Full Text] [Related]
8. Cutaneous biodistribution of ionizable, biolabile aciclovir prodrugs after short duration topical iontophoresis: Targeted intraepidermal drug delivery.
Chen Y; Zahui T; Alberti I; Kalia YN
Eur J Pharm Biopharm; 2016 Feb; 99():94-102. PubMed ID: 26592154
[TBL] [Abstract][Full Text] [Related]
9. Delivery of nalbuphine and its prodrugs across skin by passive diffusion and iontophoresis.
Sung KC; Fang JY; Hu OY
J Control Release; 2000 Jun; 67(1):1-8. PubMed ID: 10773323
[TBL] [Abstract][Full Text] [Related]
10. Influencing factors and drug application of iontophoresis in transdermal drug delivery: an overview of recent progress.
Wang Y; Zeng L; Song W; Liu J
Drug Deliv Transl Res; 2022 Jan; 12(1):15-26. PubMed ID: 33486687
[TBL] [Abstract][Full Text] [Related]
11. Transdermal iontophoresis of flufenamic acid loaded PLGA nanoparticles.
Malinovskaja-Gomez K; Labouta HI; Schneider M; Hirvonen J; Laaksonen T
Eur J Pharm Sci; 2016 Jun; 89():154-62. PubMed ID: 27131608
[TBL] [Abstract][Full Text] [Related]
12. Non-invasive iontophoretic delivery of enzymatically active ribonuclease A (13.6 kDa) across intact porcine and human skins.
Dubey S; Kalia YN
J Control Release; 2010 Aug; 145(3):203-9. PubMed ID: 20423719
[TBL] [Abstract][Full Text] [Related]
13. Topical iontophoretic delivery of ionizable, biolabile aciclovir prodrugs: A rational approach to improve cutaneous bioavailability.
Chen Y; Alberti I; Kalia YN
Eur J Pharm Biopharm; 2016 Feb; 99():103-13. PubMed ID: 26686649
[TBL] [Abstract][Full Text] [Related]
14. Iontophoresis for the cutaneous delivery of nanoentraped drugs.
Andrade JFM; Cunha-Filho M; Gelfuso GM; Gratieri T
Expert Opin Drug Deliv; 2023 Jun; 20(6):785-798. PubMed ID: 37119173
[TBL] [Abstract][Full Text] [Related]
15. Effects of chemical and physical enhancement techniques on transdermal delivery of 3-fluoroamphetamine hydrochloride.
Puri A; Murnane KS; Blough BE; Banga AK
Int J Pharm; 2017 Aug; 528(1-2):452-462. PubMed ID: 28633107
[TBL] [Abstract][Full Text] [Related]
16. Enhanced topical paromomycin delivery for cutaneous leishmaniasis treatment: Passive and iontophoretic approaches.
de Sá FAP; Andrade JFM; Miranda TC; Cunha-Filho M; Gelfuso GM; Lapteva M; Kalia YN; Gratieri T
Int J Pharm; 2023 Dec; 648():123617. PubMed ID: 37977289
[TBL] [Abstract][Full Text] [Related]
17. Effect of permeation enhancers on the iontophoretic transport of metoprolol tartrate and the drug retention in skin.
Nair A; Vyas H; Shah J; Kumar A
Drug Deliv; 2011 Jan; 18(1):19-25. PubMed ID: 20726811
[TBL] [Abstract][Full Text] [Related]
18. In vitro transdermal iontophoretic delivery of leuprolide-mechanisms under constant voltage application.
Kochhar C; Imanidis G
J Pharm Sci; 2003 Jan; 92(1):84-96. PubMed ID: 12486685
[TBL] [Abstract][Full Text] [Related]
19. Potential of iontophoresis as a drug delivery method for midazolam in pediatrics.
Djabri A; Guy RH; Delgado-Charro MB
Eur J Pharm Sci; 2019 Feb; 128():137-143. PubMed ID: 30503379
[TBL] [Abstract][Full Text] [Related]
20. Differential rates of percutaneous absorption through the eczematous and normal skin of a monkey.
Bronaugh RL; Weingarten DP; Lowe NJ
J Invest Dermatol; 1986 Oct; 87(4):451-3. PubMed ID: 3760609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
